Stroke Recurrence
7
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Cerebral Small Vessel Disease Progression Dependent on Stroke Type
NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks
Mobile Health Dietary Intervention for Stroke Survivors With Prediabetes or Type 2 Diabetes
Cilostazol for Prevention of Recurrent Stroke Trial
Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke
Post-stroke Depression Treatment Effect on Stroke Recurrence
Prevent Return of Stroke Study